BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 10617569)

  • 1. Molecular determinants of nuclear receptor-corepressor interaction.
    Perissi V; Staszewski LM; McInerney EM; Kurokawa R; Krones A; Rose DW; Lambert MH; Milburn MV; Glass CK; Rosenfeld MG
    Genes Dev; 1999 Dec; 13(24):3198-208. PubMed ID: 10617569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains.
    Cohen RN; Brzostek S; Kim B; Chorev M; Wondisford FE; Hollenberg AN
    Mol Endocrinol; 2001 Jul; 15(7):1049-61. PubMed ID: 11435607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel role for helix 12 of retinoid X receptor in regulating repression.
    Zhang J; Hu X; Lazar MA
    Mol Cell Biol; 1999 Sep; 19(9):6448-57. PubMed ID: 10454590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TR surfaces and conformations required to bind nuclear receptor corepressor.
    Marimuthu A; Feng W; Tagami T; Nguyen H; Jameson JL; Fletterick RJ; Baxter JD; West BL
    Mol Endocrinol; 2002 Feb; 16(2):271-86. PubMed ID: 11818500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A regulatory role for RIP140 in nuclear receptor activation.
    Treuter E; Albrektsen T; Johansson L; Leers J; Gustafsson JA
    Mol Endocrinol; 1998 Jun; 12(6):864-81. PubMed ID: 9626662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional analyses of an LXXLL motif in nuclear receptor corepressor (N-CoR).
    Loinder K; Söderström M
    J Steroid Biochem Mol Biol; 2004 Aug; 91(4-5):191-6. PubMed ID: 15336696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of corepressor binding and release from nuclear hormone receptors.
    Nagy L; Kao HY; Love JD; Li C; Banayo E; Gooch JT; Krishna V; Chatterjee K; Evans RM; Schwabe JW
    Genes Dev; 1999 Dec; 13(24):3209-16. PubMed ID: 10617570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic stabilization of nuclear receptor ligand binding domains by hormone or corepressor binding.
    Pissios P; Tzameli I; Kushner P; Moore DD
    Mol Cell; 2000 Aug; 6(2):245-53. PubMed ID: 10983973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two receptor interacting domains in the nuclear hormone receptor corepressor RIP13/N-CoR.
    Seol W; Mahon MJ; Lee YK; Moore DD
    Mol Endocrinol; 1996 Dec; 10(12):1646-55. PubMed ID: 8961273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nuclear corepressors recognize distinct nuclear receptor complexes.
    Cohen RN; Putney A; Wondisford FE; Hollenberg AN
    Mol Endocrinol; 2000 Jun; 14(6):900-14. PubMed ID: 10847591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential recognition of liganded and unliganded thyroid hormone receptor by retinoid X receptor regulates transcriptional repression.
    Zhang J; Zamir I; Lazar MA
    Mol Cell Biol; 1997 Dec; 17(12):6887-97. PubMed ID: 9372920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions that determine the assembly of a retinoid X receptor/corepressor complex.
    Ghosh JC; Yang X; Zhang A; Lambert MH; Li H; Xu HE; Chen JD
    Proc Natl Acad Sci U S A; 2002 Apr; 99(9):5842-7. PubMed ID: 11972046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators.
    Tagami T; Lutz WH; Kumar R; Jameson JL
    Biochem Biophys Res Commun; 1998 Dec; 253(2):358-63. PubMed ID: 9878542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corepressor SMRT functions as a coactivator for thyroid hormone receptor T3Ralpha from a negative hormone response element.
    Berghagen H; Ragnhildstveit E; Krogsrud K; Thuestad G; Apriletti J; Saatcioglu F
    J Biol Chem; 2002 Dec; 277(51):49517-22. PubMed ID: 12388540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-function analysis of the Rev-erbA and RVR ligand-binding domains reveals a large hydrophobic surface that mediates corepressor binding and a ligand cavity occupied by side chains.
    Renaud JP; Harris JM; Downes M; Burke LJ; Muscat GE
    Mol Endocrinol; 2000 May; 14(5):700-17. PubMed ID: 10809233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of retinoid receptor coactivator pockets in cofactor recruitment and transcriptional regulation.
    Leo C; Yang X; Liu J; Li H; Chen JD
    J Biol Chem; 2001 Jun; 276(25):23127-34. PubMed ID: 11274211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of receptor interaction and transcriptional repression by the corepressor SMRT.
    Li H; Leo C; Schroen DJ; Chen JD
    Mol Endocrinol; 1997 Dec; 11(13):2025-37. PubMed ID: 9415406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic retinoids dissociate coactivator binding from corepressor release.
    Zechel C
    J Recept Signal Transduct Res; 2002; 22(1-4):31-61. PubMed ID: 12503607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3.
    Li J; Wang J; Wang J; Nawaz Z; Liu JM; Qin J; Wong J
    EMBO J; 2000 Aug; 19(16):4342-50. PubMed ID: 10944117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT.
    Huynh KD; Bardwell VJ
    Oncogene; 1998 Nov; 17(19):2473-84. PubMed ID: 9824158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.